28 July 2025: Kynetyka is delighted to announce that it has secured funding of $500,000 from AusHealth, an Australian medical research charity. This investment will support the development of DVTect®, by funding a clinical study at the Royal Adelaide Hospital and software development by Adelaide-based HeartAI. Working in close partnership, the data collected from the study will be used to optimize DVTect® and provide robust sensitivity and specificity statistics as required by clinicians and regulators.

For the full release, click here